Dov A MD Goldstein is a director of Coya Therapeutics, Inc.
Person profile
Roles
Employees
Incorporated
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
3
BioAge Labs, Inc.
25 Sep 24
4
Gain Therapeutics, Inc.
26 Jun 24
4
Coya Therapeutics, Inc.
19 Jan 24
4
Gain Therapeutics, Inc.
26 Jun 23
4
Coya Therapeutics, Inc.
4 Jan 23
3
Coya Therapeutics, Inc.
28 Dec 22
4
Gain Therapeutics, Inc.
22 Sep 22
4
NeuBase Therapeutics, Inc.
12 Sep 22
4
NeuBase Therapeutics, Inc.
17 Sep 21
4
NeuBase Therapeutics, Inc.
21 Jun 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
24 Jun 24 | GANX Gain Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.29 | 15,000 | 19.35 k | 15,000 |
1 Jan 24 | COYA Coya Therapeutics | Stock Option Common Stock, par value $0.0001 per share | Grant | Acquire A | No | No | 7.41 | 5,000 | 37.05 k | 5,000 |
23 Jun 23 | GANX Gain Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 4.5 | 10,500 | 47.25 k | 10,500 |